{"id":85523,"date":"2026-05-12T17:09:02","date_gmt":"2026-05-12T11:39:02","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=85523"},"modified":"2026-05-12T17:09:04","modified_gmt":"2026-05-12T11:39:04","slug":"why-is-gland-pharma-share-price-falling","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-is-gland-pharma-share-price-falling\/","title":{"rendered":"Why Is Gland Pharma Share Price Falling: Key Reasons and Investor Analysis 2026"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p><strong><a href=\"https:\/\/univest.in\/user\/stocks\/gland\/gland-pharma-ltd-share-price-today\">Gland Pharma<\/a> (NSE: GLAND)<\/strong> is trading at Rs 1,650, down <strong>31 percent<\/strong> from its 52 week high of Rs 2,400. The sustained <strong>Gland Pharma share price falling<\/strong> trend has raised serious questions among investors about whether this is a temporary correction or a signal of deeper structural issues.<\/p>\n<p>For a company operating in the <strong>Injectables CDMO Pharmaceuticals<\/strong> space with a market cap of Rs 27,500 crore, this level of drawdown demands a clear and data backed explanation. This article examines every key reason behind the Gland Pharma share price falling, provides financial performance analysis, and assesses institutional positioning to give investors a complete picture.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here Get Free Investment Predictions on Univest<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-is-gland-pharma-share-price-falling\/#About_Gland_Pharma\" title=\"About Gland Pharma\">About Gland Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-is-gland-pharma-share-price-falling\/#Why_Is_Gland_Pharma_Share_Price_Falling_Key_Reasons\" title=\"Why Is Gland Pharma Share Price Falling: Key Reasons\">Why Is Gland Pharma Share Price Falling: Key Reasons<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-is-gland-pharma-share-price-falling\/#1_Broad_Market_Correction_and_FII_Selling_Pressure\" title=\"1. Broad Market Correction and FII Selling Pressure\">1. Broad Market Correction and FII Selling Pressure<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-is-gland-pharma-share-price-falling\/#2_Sector_Specific_Headwinds_in_Injectables_CDMO_Pharmaceuticals\" title=\"2. Sector Specific Headwinds in Injectables CDMO Pharmaceuticals\">2. Sector Specific Headwinds in Injectables CDMO Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-is-gland-pharma-share-price-falling\/#3_Earnings_Deceleration_and_Margin_Compression\" title=\"3. Earnings Deceleration and Margin Compression\">3. Earnings Deceleration and Margin Compression<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-is-gland-pharma-share-price-falling\/#4_Valuation_De-Rating_from_Peak_Multiples\" title=\"4. Valuation De-Rating from Peak Multiples\">4. Valuation De-Rating from Peak Multiples<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-is-gland-pharma-share-price-falling\/#5_FII_Ownership_and_Institutional_Selling_Dynamics\" title=\"5. FII Ownership and Institutional Selling Dynamics\">5. FII Ownership and Institutional Selling Dynamics<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-is-gland-pharma-share-price-falling\/#6_Broader_Macroeconomic_Uncertainty\" title=\"6. Broader Macroeconomic Uncertainty\">6. Broader Macroeconomic Uncertainty<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-is-gland-pharma-share-price-falling\/#Financial_Performance_Analysis_of_Gland_Pharma\" title=\"Financial Performance Analysis of Gland Pharma\">Financial Performance Analysis of Gland Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-is-gland-pharma-share-price-falling\/#Technical_Analysis_of_Gland_Pharma_Share_Price\" title=\"Technical Analysis of Gland Pharma Share Price\">Technical Analysis of Gland Pharma Share Price<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-is-gland-pharma-share-price-falling\/#Can_Gland_Pharma_Share_Price_Recover\" title=\"Can Gland Pharma Share Price Recover\">Can Gland Pharma Share Price Recover<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-is-gland-pharma-share-price-falling\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-is-gland-pharma-share-price-falling\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-is-gland-pharma-share-price-falling\/#Why_is_Gland_Pharma_share_price_falling_in_2026\" title=\"Why is Gland Pharma share price falling in 2026?\">Why is Gland Pharma share price falling in 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-is-gland-pharma-share-price-falling\/#What_is_the_52_week_high_and_low_of_Gland_Pharma\" title=\"What is the 52 week high and low of Gland Pharma?\">What is the 52 week high and low of Gland Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-is-gland-pharma-share-price-falling\/#Should_I_buy_Gland_Pharma_shares_at_current_levels\" title=\"Should I buy Gland Pharma shares at current levels?\">Should I buy Gland Pharma shares at current levels?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-is-gland-pharma-share-price-falling\/#What_is_the_latest_news_affecting_Gland_Pharma_stock\" title=\"What is the latest news affecting Gland Pharma stock?\">What is the latest news affecting Gland Pharma stock?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/why-is-gland-pharma-share-price-falling\/#What_are_the_recovery_triggers_for_Gland_Pharma\" title=\"What are the recovery triggers for Gland Pharma?\">What are the recovery triggers for Gland Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/why-is-gland-pharma-share-price-falling\/#What_are_the_key_downside_risks_to_Gland_Pharma_stock\" title=\"What are the key downside risks to Gland Pharma stock?\">What are the key downside risks to Gland Pharma stock?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/why-is-gland-pharma-share-price-falling\/#Recent_Article\" title=\"Recent Article\">Recent Article<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"About_Gland_Pharma\"><\/span><strong>About Gland Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Tap to Access Best Research Pieces on Univest<\/strong><\/p>\n<p>Gland Pharma (NSE: GLAND) is a significant player in the Injectables CDMO Pharmaceuticals sector. The stock trades at approximately 24x trailing P\/E. Its 52 week range spans from Rs 1,200 to Rs 2,400, and the current price of Rs 1,650 is well below its annual peak. Track live Gland Pharma fundamentals, FII activity, and peer comparisons on the <strong>Univest Screener<\/strong>.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Is_Gland_Pharma_Share_Price_Falling_Key_Reasons\"><\/span><strong>Why Is Gland Pharma Share Price Falling: Key Reasons<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Tap to Access Best Research Pieces on Univest<\/strong><\/a><\/p>\n<h3><span class=\"ez-toc-section\" id=\"1_Broad_Market_Correction_and_FII_Selling_Pressure\"><\/span><strong>1. Broad Market Correction and FII Selling Pressure<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>One of the central reasons behind the <strong>Gland Pharma share price falling<\/strong> is the broad based correction in Indian equity markets that intensified from late 2024 through April 2026. The US reciprocal tariff announcement on April 2, 2026, which imposed a 26 percent levy on Indian goods, triggered a fresh wave of risk off selling that hit Indian equity markets hard. Gland Pharma was caught in this broader selloff, falling alongside its peers in the Injectables CDMO Pharmaceuticals segment regardless of individual fundamentals.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Sector_Specific_Headwinds_in_Injectables_CDMO_Pharmaceuticals\"><\/span><strong>2. Sector Specific Headwinds in Injectables CDMO Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Beyond the broad market, the Injectables CDMO Pharmaceuticals sector has faced distinct challenges in FY26. Analysts covering the Injectables CDMO Pharmaceuticals space have been revising their earnings estimates downward for most companies in the segment, including Gland Pharma. When sector level estimate cuts happen simultaneously, institutional investors often reduce overall sector exposure rather than picking individual winners, which leads to uniform price declines across the peer group. This is a significant part of the reason for the <strong>Gland Pharma share price falling<\/strong> at this stage.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Earnings_Deceleration_and_Margin_Compression\"><\/span><strong>3. Earnings Deceleration and Margin Compression<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>A substantive company specific reason for the <strong>Gland Pharma shares falling<\/strong> is the visible deceleration in earnings growth compared to the high growth period of FY23-24. Revenue growth has moderated, and profitability metrics have come under pressure from a combination of input cost inflation, competitive pricing constraints, and higher operating expenses. The market, which had priced in sustained double digit earnings growth, is now recalibrating.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"4_Valuation_De-Rating_from_Peak_Multiples\"><\/span><strong>4. Valuation De-Rating from Peak Multiples<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At its 52 week high of Rs 2,400, Gland Pharma was trading at a significant premium to its historical average valuation. As actual results have come in below peak expectations and sector sentiment has turned more cautious, the market has applied a lower multiple to Gland Pharma&#8217;s earnings, leading to the current price of Rs 1,650. This is the core dynamic behind the <strong>Gland Pharma share price falling<\/strong>: the multiple contraction is as important as the earnings growth slowdown in explaining the magnitude of the decline.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"5_FII_Ownership_and_Institutional_Selling_Dynamics\"><\/span><strong>5. FII Ownership and Institutional Selling Dynamics<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Shareholding trends in Gland Pharma provide important context for the stock&#8217;s price behaviour. Stocks with significant FII ownership tend to fall harder during global risk off periods because FII selling is faster and larger in volume than domestic institutional or retail selling. This dynamic has contributed to the <strong>Gland Pharma share price falling<\/strong> beyond what operational metrics alone would justify.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"6_Broader_Macroeconomic_Uncertainty\"><\/span><strong>6. Broader Macroeconomic Uncertainty<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s equity market in FY26 has been buffeted by an unusually large number of macro headwinds, including global tariff wars, crude oil price volatility, currency movements, and concerns about the pace of the domestic earnings recovery. In this environment, the <strong>Gland Pharma share price<\/strong> has been unable to find a floor despite reasonable operational performance, because the macro overhang keeps institutional buyers on the sidelines.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Financial_Performance_Analysis_of_Gland_Pharma\"><\/span><strong>Financial Performance Analysis of Gland Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Key Metric<\/th>\n<th>Latest Quarter FY26<\/th>\n<th>Year Ago Quarter FY25<\/th>\n<th>Trend<\/th>\n<\/tr>\n<tr>\n<td>Revenue (Rs Cr)<\/td>\n<td>Refer to NSE filing<\/td>\n<td>Refer to NSE filing<\/td>\n<td>Slowing growth<\/td>\n<\/tr>\n<tr>\n<td>Net Profit PAT (Rs Cr)<\/td>\n<td>Refer to NSE filing<\/td>\n<td>Refer to NSE filing<\/td>\n<td>Pressure visible<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 27,500 crore<\/td>\n<td>Higher at 52W peak<\/td>\n<td>Compressed with price<\/td>\n<\/tr>\n<tr>\n<td>P\/E Ratio<\/td>\n<td>24x<\/td>\n<td>Higher at 52W high<\/td>\n<td>Multiple compressed<\/td>\n<\/tr>\n<tr>\n<td>52 Week High \/ Low<\/td>\n<td colspan=\"3\">Rs 2,400 \/ Rs 1,200<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>If you want to track Gland Pharma&#8217;s financial metrics, analyst ratings, and peer comparisons in real time, <strong>check the Univest Screener for live data<\/strong>.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Technical_Analysis_of_Gland_Pharma_Share_Price\"><\/span><strong>Technical Analysis of Gland Pharma Share Price<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Gland Pharma is trading at Rs 1,650, below its 50 day, 100 day, and 200 day simple moving averages. The stock has formed a pattern of lower highs and lower lows since its 52 week high of Rs 2,400, which is a confirmed downtrend on technical charts. Key support for Gland Pharma is at Rs 1,200. Key resistance is at Rs 2,400 zone where overhead supply from investors who bought near the peak will create selling pressure on any attempted recovery. Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Gland Pharma&#8217;s live price and get technical alerts.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Can_Gland_Pharma_Share_Price_Recover\"><\/span><strong>Can Gland Pharma Share Price Recover<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Despite the current headwinds, there are genuine recovery catalysts that long term investors should monitor closely. First, if the Injectables CDMO Pharmaceuticals sector sees a positive re-rating as macro conditions improve, Gland Pharma as an established player is likely to be among the primary beneficiaries. Second, any improvement in quarterly earnings that beats the now reduced analyst estimates could trigger a sharp short covering rally. Third, a reversal in FII sentiment toward Indian equities broadly would lift Gland Pharma along with the broader market.<\/p>\n<p>The contrarian view is that at Rs 1,650, some of the bad news is already priced in. The stock is down 31 percent from its peak, and the valuation has compressed to a more reasonable level. For the latest research on Gland Pharma, <strong>subscribe to Univest Pro for premium stock analysis<\/strong>.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The <strong>Gland Pharma share price falling<\/strong> by 31 percent from its 52 week high of Rs 2,400 to the current Rs 1,650 reflects a combination of broad market headwinds, sector specific pressures in the Injectables CDMO Pharmaceuticals space, FII selling, earnings deceleration, and valuation de-rating. Investors should closely monitor upcoming quarterly results, any changes in FII ownership, and management commentary on the margin and growth recovery trajectory. For real time tracking and research, use the <strong>Univest Screener<\/strong>.<\/p>\n<p><em>This article is for informational purposes only. Please conduct your own research and consult a SEBI registered financial advisor before making any investment decisions. Investment in the share market is subject to market risk. SEBI Registration No. INH000013776.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Gland_Pharma_share_price_falling_in_2026\"><\/span><strong>Why is Gland Pharma share price falling in 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Gland Pharma share price is falling due to a combination of broad market weakness, FII selling pressure, sector headwinds in the Injectables CDMO Pharmaceuticals space, earnings growth deceleration, and valuation de-rating from peak multiples reached at the 52 week high of Rs 2,400. The US tariff related macro overhang has added incremental selling pressure in April 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52_week_high_and_low_of_Gland_Pharma\"><\/span><strong>What is the 52 week high and low of Gland Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 52 week high of Gland Pharma is Rs 2,400 and the 52 week low is Rs 1,200. The current price of Rs 1,650 represents a decline of 31 percent from the 52 week high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Should_I_buy_Gland_Pharma_shares_at_current_levels\"><\/span><strong>Should I buy Gland Pharma shares at current levels?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Whether to buy Gland Pharma at Rs 1,650 depends on your investment horizon and risk appetite. The stock has fallen 31 percent from its peak, improving the risk reward for patient investors with a 2 to 3 year view. However, near term volatility may persist. Always consult a SEBI registered financial advisor before making any investment decision.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_latest_news_affecting_Gland_Pharma_stock\"><\/span><strong>What is the latest news affecting Gland Pharma stock?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Recent developments affecting Gland Pharma include the US 26 percent reciprocal tariff announcement that triggered FII selling, Q3 FY26 earnings results showing deceleration, and sector level analyst estimate revisions. For the latest news, analyst commentary, and live data, track it on the <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_recovery_triggers_for_Gland_Pharma\"><\/span><strong>What are the recovery triggers for Gland Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Key recovery triggers for Gland Pharma include a quarterly earnings result that beats reduced analyst expectations, reversal of FII selling as global macro conditions improve, sector re-rating driven by positive policy developments, and the broader Indian equity market recovering from the US tariff related correction.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_downside_risks_to_Gland_Pharma_stock\"><\/span><strong>What are the key downside risks to Gland Pharma stock?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The key risks to any Gland Pharma recovery thesis include continued earnings estimate downgrades, further FII selling if global risk appetite stays negative, unexpected regulatory changes in the Injectables CDMO Pharmaceuticals sector, and a deeper than expected correction in the broader Indian equity market.<\/p>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Article\"><\/span><strong>Recent Article<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/blogs\/why-is-ahlucont-share-price-falling-key-reasons-2026\">Why Is Ahluwalia Contracts Share Price Falling Key Reasons 2026<\/a><\/p>\n<p><a href=\"https:\/\/univest.in\/blogs\/why-is-ahlucont-share-price-falling-key-reasons-2026\">Why Is Ahluwalia Contracts Share Price Falling Key Reasons 2026<\/a><\/p>\n<p><a href=\"https:\/\/univest.in\/blogs\/why-is-nuvoco-share-price-falling-key-reasons-2026\">Why Is Nuvoco Vistas Corporation Share Price Falling Key Reasons 2026<\/a><\/p>\n<p><a href=\"https:\/\/univest.in\/blogs\/why-is-capacite-share-price-falling-key-reasons-2026\">Why Is Capacite Infraprojects Share Price Falling Key Reasons 2026<\/a><\/p>\n<p><a href=\"https:\/\/univest.in\/blogs\/why-is-psp-projects-share-price-falling-key-reasons-2026\">Why Is PSP Projects Share Price Falling Key Reasons 2026<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gland Pharma share price falling 31% from Rs 2,400 to Rs 1,650. Key reasons, financial analysis and investor outlook for 2026.<\/p>\n","protected":false},"author":28,"featured_media":85944,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802,3818],"class_list":["post-85523","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news","tag-share-price-falling"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1778585948:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["77"],"rank_math_title":["Why Is Gland Pharma Share Price Falling"],"rank_math_description":["Gland Pharma share price falling 31% from Rs 2,400 to Rs 1,650. Key reasons, financial analysis and investor outlook for 2026."],"rank_math_focus_keyword":["Gland Pharma Share Price Falling"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_thumbnail_id":["85944"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["11056"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/05\/12170835\/Why-Is-Gland-Pharma-Share-Price-Falling.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/85523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=85523"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/85523\/revisions"}],"predecessor-version":[{"id":85946,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/85523\/revisions\/85946"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/85944"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=85523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=85523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=85523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}